These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19480060)

  • 1. Microbicide data show promise.
    AIDS Patient Care STDS; 2009 Mar; 23(3):223-4. PubMed ID: 19480060
    [No Abstract]   [Full Text] [Related]  

  • 2. Is HIV drug resistance a limiting factor in the development of anti-HIV NNRTI and NRTI-based vaginal microbicide strategies?
    Martinez J; Coplan P; Wainberg MA
    Antiviral Res; 2006 Sep; 71(2-3):343-50. PubMed ID: 16787667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbicide offers no protection against HIV infection.
    Roehr B
    BMJ; 2009 Dec; 339():b5538. PubMed ID: 20022912
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women.
    Abdool Karim SS; Richardson BA; Ramjee G; Hoffman IF; Chirenje ZM; Taha T; Kapina M; Maslankowski L; Coletti A; Profy A; Moench TR; Piwowar-Manning E; Mâsse B; Hillier SL; Soto-Torres L;
    AIDS; 2011 Apr; 25(7):957-66. PubMed ID: 21330907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing HIV-1 sexual transmission--not sexy enough science, or no benefit to the bottom line?
    Moore JP; Shattock RJ
    J Antimicrob Chemother; 2003 Dec; 52(6):890-2. PubMed ID: 14613946
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaginal microbicides: moving ahead after an unexpected setback.
    van de Wijgert JH; Shattock RJ
    AIDS; 2007 Nov; 21(18):2369-76. PubMed ID: 18025873
    [No Abstract]   [Full Text] [Related]  

  • 7. Uptake of biomedical interventions for prevention of sexually transmitted HIV.
    Abbas UL
    Curr Opin HIV AIDS; 2011 Mar; 6(2):114-8. PubMed ID: 21505385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding basic mechanisms and optimizing assays to evaluate the efficacy of vaginal microbicides.
    Keller MJ; Herold BC
    Sex Transm Dis; 2009 Mar; 36(3 Suppl):S92-5. PubMed ID: 19218889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The need for a "condoms-only" control group in microbicide trials.
    Jones H; van de Wijgert J; Kelvin E
    Epidemiology; 2003 Jul; 14(4):505; author reply 505-6. PubMed ID: 12843779
    [No Abstract]   [Full Text] [Related]  

  • 10. PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial.
    Keller MJ; Zerhouni-Layachi B; Cheshenko N; John M; Hogarty K; Kasowitz A; Goldberg CL; Wallenstein S; Profy AT; Klotman ME; Herold BC
    J Infect Dis; 2006 Jan; 193(1):27-35. PubMed ID: 16323128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal gel may prevent herpes transmission.
    AIDS Patient Care STDS; 2005 May; 19(5):351. PubMed ID: 15948277
    [No Abstract]   [Full Text] [Related]  

  • 12. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
    Abdool Karim SS
    Future Microbiol; 2010 Apr; 5(4):527-9. PubMed ID: 20353292
    [No Abstract]   [Full Text] [Related]  

  • 13. Risk of contracting HIV.
    AIDS Patient Care STDS; 2001 May; 15(5):292. PubMed ID: 11530773
    [No Abstract]   [Full Text] [Related]  

  • 14. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbicides. Raising new barriers against HIV infection.
    Trager RS
    Science; 2003 Jan; 299(5603):39. PubMed ID: 12511630
    [No Abstract]   [Full Text] [Related]  

  • 16. Starting to gel.
    Pilcher H
    Nature; 2004 Jul; 430(6996):138-40. PubMed ID: 15241385
    [No Abstract]   [Full Text] [Related]  

  • 17. HIV can penetrate healthy genital skin.
    AIDS Patient Care STDS; 2009 Feb; 23(2):139-40. PubMed ID: 19480051
    [No Abstract]   [Full Text] [Related]  

  • 18. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 19. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV.
    Turpin JA
    Expert Opin Investig Drugs; 2002 Aug; 11(8):1077-97. PubMed ID: 12150703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health. Regulatory challenges in microbicide development.
    Coplan PM; Mitchnick M; Rosenberg ZF
    Science; 2004 Jun; 304(5679):1911-2. PubMed ID: 15218130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.